CFC
BSX icon

Coyle Financial Counsel’s Boston Scientific BSX Stock Holding History

Coyle Financial Counsel’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,495
Closed -$219K – 128
2026
Q1 		$219K Sell
3,495
-65
-2% -$5.2K 0.05% 105
2025
Q4 		$339K Sell
3,560
-469
-12% -$46K 0.07% 84
2025
Q3 		$393K Buy
4,029
+858
+27% +$88.9K 0.09% 72
2025
Q2 		$341K Buy
+3,171
New +$321K 0.09% 68
2018
Q3 		– Sell
-60
Closed -$2K – 69
2018
Q2 		$2K Buy
+60
New +$1.81K ﹤0.01% 275

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Coyle Financial Counsel's BSX Position: Q2 2026 in Review

Coyle Financial Counsel sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,495 shares — an estimated $219K sold.

Coyle Financial Counsel first reported a position in BSX in Q2 2018 and held it in 5 quarters. The position peaked at $393K in Q3 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Coyle Financial Counsel reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Coyle Financial Counsel sold 3,495 Boston Scientific shares in Q2 2026, an estimated $219K.
  • Coyle Financial Counsel first reported a position in Boston Scientific in Q2 2018 and held it in 5 quarters.
  • Coyle Financial Counsel's Boston Scientific position peaked at $393K in Q3 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Coyle Financial Counsel's 13F filing for Q2 2026, filed 7 Aug 2026.